Tornar a notícies
Two ICREA spin offs obtain funding from H2020 SME support instrument. The entrepreneurs Laura Soucek (ICREA at VHIO) and Roger Gomis (ICREA at IRB) have both secured a bunch of money from H2020 SME instrument this week. Their two companies are attacking different aspects of cancer tumors. Inbiomotion, Roger’s company is testing a platform to prevent breast cancer from invading bone marrow. Peptomyc, Laura’s company, has invented an innovative mollecule that blocks one of the most critical oncogenes, applicable to a wide array of different tumors.
Congratulations Laura and Roger, and keep up the good work!
More details? Click here.
OTHER NEWS
Premi ‘Fundación Real Academia de Ciencias al Joven Talento Científico Femenino 2024’
La Professora d'Investigació ICREA María Escudero Escribano (ICN2) rep aquest premi en la categoria de 'Física, Química i Ciències afins'.…
ICREA call 2025 is open
Each year ICREA opens a call for permanent positions in the Catalan research system for senior researchers. The selected researchers…
